H.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising Pharma

H.I.G. Capital is exploring options for its controlling stake in US-based Rising Pharmaceuticals, including a possible sale, according to people familiar with the matter.

By Baiju Kalesh and Ranjani Raghavan · Bloomberg Markets

H.I.G. Capital is exploring options for its controlling stake in US-based Rising Pharmaceuticals, including a possible sale, according to people familiar with the matter.